Valuation (14%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -114.07 | -19.17 |
PEG Ratio (TTM) | 2.63 | -5.61 |
P/S Ratio (TTM) | N/A | 41.30 |
P/B Ratio (TTM) | 5.49 | 5.67 |
P/FCF Ratio (TTM) | -111.20 | -148.36 |
Price to 5YR AVG Earnings Ratio | N/A | -33.81 |
Price to 5YR AVG FCF Ratio | N/A | -1.26 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -1.79% | 291.32% |
ROE (TTM) | -4.75% | -4,280.27% |
Net Profit Margin (TTM) | N/A | -1,106.71% |
ROIC 5YR AVG | N/A | -16.06% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -10.46% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -7.61% | N/A | N/A |
Cash Flow | -189.11% | N/A | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.22 | 4.95 |
Quick Ratio (TTM) | 0.22 | 4.93 |
D/E Ratio (TTM) | 0.06 | 1.29 |
Interest Coverage (TTM) | N/A | -11.14 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 1.90 | 21.20 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 887.86% |